76 Ces Urol 2023; 27(2): 70-77 PŘEHLEDOVÉ ČLÁNKY 8. Pitra T, Pivovarcikova K, Alaghehbandan R, Hes O. Chromosomal numerical aberration pattern in papillary renal cell carcinoma: Review article. Ann Diagn Pathol. 2019; 40: 189–199. 9. Pivovarcikova K, Peckova K, Martinek P, et al. „Mucin“-secreting papillary renal cell carcinoma: clinico‑ pathological, immunohistochemical, and molecular genetic analysis of seven cases. Virchows Arch. 2016; 469(1): 71–80. 10. Rogala J, Kojima F, Alaghehbandan R, et al. Papillary renal cell carcinoma with prominent spindle cell stroma – tumor mimicking mixed epithelial and stromal tumor of the kidney: Clinicopathologic, morpho‑ logic, immunohistochemical and molecular genetic analysis of 6 cases. Ann Diagn Pathol. 2020; 44: 151441. 11. Ulamec M, Skenderi F, Trpkov K, et al. Solid papillary renal cell carcinoma: clinicopathologic, mor‑ phologic, and immunohistochemical analysis of 10 cases and review of the literature. Ann Diagn Pathol. 2016; 23: 51–57. 12. Skenderi F, Ulamec M, Vanecek T, et al. Warthin‑like papillary renal cell carcinoma: Clinicopathologic, morphologic, immunohistochemical and molecular genetic analysis of 11 cases. Ann Diagn Pathol. 2017; 27: 48–56. 13. Hes O, Condom Mundo E, Peckova K, et al. Biphasic Squamoid Alveolar Renal Cell Carcinoma: A Dis‑ tinctive Subtype of Papillary Renal Cell Carcinoma? Am J Surg Pathol. 2016; 40(5): 664–675. 14. Pivovarcikova K, Grossmann P, Hajkova V, et al. Renal cell carcinomas with tubulopapillary architecture and oncocytic cells: Molecular analysis of 39 difficult tumors to classify. Ann Diagn Pathol. 2021; 52: 151734. 15. Williamson SR, Hes O, Trpkov K, et al. Low‑grade oncocytic tumour of the kidney is characterised by genetic alterations of TSC1, TSC2, MTOR or PIK3CA and consistent GATA3 positivity. Histopathology. 2023; 82(2): 296–304. 16. He H, Trpkov K, Martinek P, et al. „High‑grade oncocytic renal tumor“: morphologic, immunohisto‑ chemical, and molecular genetic study of 14 cases. Virchows Arch. 2018; 473(6): 725–738. 17. Farcaş M, Gatalica Z, Trpkov K, et al. Eosinophilic vacuolated tumor (EVT) of kidney demonstrates sporadic TSC/MTOR mutations: next‑generation sequencing multi‑institutional study of 19 cases. Mod Pathol. 2022; 35(3): 344–351. 18. Pivovarcikova K, Alaghehbandan R, Vanecek T, et al. TSC/mTOR Pathway Mutation Associated Eo‑ sinophilic/Oncocytic Renal Neoplasms: A Heterogeneous Group of Tumors with Distinct Morphology, Immunohistochemical Profile, and Similar Genetic Background. Biomedicines. 2022; 10(2): 322. 19. Hora M, Albiges L, Bedke J, et al. European Association of Urology Guidelines Panel on Renal Cell Carcinoma Update on the New World Health Organization Classification of Kidney Tumours 2022: The Urologist’s Point of View. Eur Urol. 2023; 83(2): 97–100. 20. Williamson SR. Clear cell papillary renal cell carcinoma: an update after 15 years. Pathology 2021; 53(1): 109–119. 21. Trpkov K, Hes O, Bonert M, et al. Eosinophilic, Solid, and Cystic Renal Cell Carcinoma: Clinicopatho‑ logic Study of 16 Unique, Sporadic Neoplasms Occurring in Women. Am J Surg Pathol. 2016; 40(1): 60–71. 22. Mehra R, Vats P, Cao X, et al. Somatic Bi‑allelic Loss of TSC Genes in Eosinophilic Solid and Cystic Renal Cell Carcinoma. Eur Urol. 2018; 74(4): 483–486. 23. McKenney JK, Przybycin CG, Trpkov K, Magi‑Galluzzi C. Eosinophilic solid and cystic renal cell carci‑ nomas have metastatic potential. Histopathology. 2018; 72(6): 1066–1067. 24. Argani P, Reuter VE, Zhang L, et al. TFEB‑amplified Renal Cell Carcinomas: An Aggressive Molecular Subset Demonstrating Variable Melanocytic Marker Expression and Morphologic Heterogeneity. Am J Surg Pathol. 2016; 40(11): 1484–1495. 25. Peckova K, Vanecek T, Martinek P, et al. Aggressive and nonaggressive translocation t(6;11) renal cell carcinoma: comparative study of 6 cases and review of the literature. Ann Diagn Pathol. 2014; 18(6): 351–357.
RkJQdWJsaXNoZXIy NDA4Mjc=